Vertical Toxoplasmosis in a Murine Model. Protection after Immunization with Antigens of Toxoplasma gondii Incorporated into Liposomes

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue 1, 2001, Pages 99-104

  Elsaid, Mohamed M A ^a   Martins, Maria S ^a   Frézard, Frédéric ^a   Braga, Erika M ^a   Vitor, Ricardo W A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Congenital transmission; Immunoprotection; Liposomes; Mice; Toxoplasma

Indexed keywords

LIPOSOME; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CONGENITAL TOXOPLASMOSIS; DISEASE MODEL; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOLOGY; MOUSE; NEWBORN; PREGNANCY; TOXOPLASMA;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; DISEASE MODELS, ANIMAL; DISEASE TRANSMISSION, VERTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LIPOSOMES; MICE; MICE, INBRED BALB C; PREGNANCY; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 0035230317     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762001000100011     Document Type: Article

References (23)

1. Alexander J, Roberts CW, Brewer JM 1993. Progress towards the development of a vaccine against congenital toxoplasmosis: identification of protective antigens and the selection of the appropriate adjuvants. In JE Smith, Toxoplasmosis, NATO ASI Series H, vol. H 78, Elsevier Publications, Cambridge, p. 217-229.
2. Beverley JKA, Watson W 1971. Prevention of experimental and of naturally occurring ovine abortion due to toxoplasmosis. Vet Rec 88: 39-41.
3. Bradford MM 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254.
4. Bulow R, Boothroyd JC 1991. Protection of mice from fatal Toxoplasma gondii infection by immunization with P30 antigen in liposomes. J Immunol 147: 246-251.
5. Duncan DB 1955. Multiple Range and Multiple F tests. Biometrics 11: 1-42.
6. Elsaid MMA, Vitor RWA, Frézard FJG, Martins MS 1999. Protection against toxoplasmosis in mice immunized with different antigens of Toxoplasma gondii incorporated into liposomes. Mem Inst Oswaldo Cruz 94: 485-490.
7. Fux B, Ferreira AM, Cassali GD, Tafuri WL, Vitor RWA 2000. Experimental toxoplasmosis in BALB/c mice. Prevention of vertical disease transmission by treatment and reproductive failure in chronic infection. Mem Inst Oswaldo Cruz 95: 121-126.
8. Holland D, Bretsher P, Russel A 1984. Immunologic and inflammatory responses during pregnancy. J Clin Lab Immunol 14: 177-179.
9. Jamra LMF, Vieira MPL 1991. Isolamento do Toxoplasma gondii de exsudato peritoneal e órgãos de camundongos com infecção experimental. Rev Inst Med Trop São Paulo 133: 435-441.
10. Kasper LH, Currie KM, Bradley MS 1986. An unexpected response to vaccination with a purified major membrane tachyzoites antigen (P30) of Toxoplasma gondii. J Immunol 134: 3426-3432.
11. Khan IA, Smith JS, Kasper LH 1988. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol 141: 3600-3606.
12. Kirby C, Gregoriadis G 1984. Dehydration rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology 2: 979-984.
13. Luft BJ, Hafner MD, Korzun AH, Leport C, Antoniskis DEM, Boster DD, Bourland R, Ultamchndani R, Fuhrer J, Jacobson J, Morlat P, Vilde J, Remington JS 1993. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 329: 995-1000.
14. McLeod R, Frenkel JR, Estes RG, Mack DG, Eisenhauer PB, Gibbons G 1988. Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge. J Immunol 140: 1632-1637.
15. Nobrega P, Trapp E, Giovannoni M 1952. Toxoplasmose epizótica em coelhos. I. Ação da sulfadiazina. Ciēnc Cult 4: 134-135.
16. Petersen E, Nielsen HV, Christiansen L, Spenter J 1998. Immunization with E, coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 16: 1283-1289.
17. Remington JS, Mcleod R, Desmonts G 1994. Toxoplasmosis. In JS Remington, OJ Klein (eds), Infectious Disease of the Fetus and New-born Infant, WB Saunders Co, Philadelphia, p. 141-267.
18. Roberts CW, Alexander J 1992. Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitology 104: 19-23.
19. Roberts CW, Brewer JM, Alexander J 1994. Congenital toxoplasmosis in Balb/c mouse: prevention of vertical disease transmission and fetal death by vaccination. Vaccine 12: 1389-1394.
20. Thouvenin M, Candolfi E, Villard O, Klein JP, Kien T 1997. Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are Type 2-dependent. Parasitology 39: 279-283.
21. Wegmann TG, Lin A, Guilbert L, Mosmann TM 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14: 353-356.
22. Wong SY, Remington JS 1994. Toxoplasmosis in pregnancy. Clin Infect Dis 18: 853-862.
23. Yap GS, Scharton-kersten T, Ferguson DJP, Howe D, Suzuki Y, Sher A 1998. Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondii. Infect Immun 66: 4382-4388.